Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

USA Technologies, Inc. (USAT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

USA Technologies is engaged in the networking of wireless non-cash transactions, associated financial/network services and energy management. USAT provides networked credit card and other non-cash systems and services in the vending, commercial laundry, hospitality and digital imaging industries. The company … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Hangover Joe’s, Inc. (HJOE) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Hangover Joe’s is the exclusive producer of The Hangover Recovery Shot, which is the official licensed product of “The Hangover” movie and the No. 1 selling hangover recovery product in the United States. Hangover Joe’s Recovery Shot, taken the morning … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Oxford BioMedica Plc (OXB) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Oxford BioMedica is a biopharmaceutical company focused on the development of innovative treatments to improve the lives of patients with high unmet medical needs. The company’s vast pipeline of gene-based product candidates addresses the treatment of age-related or inherited neurodegenerative … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

ImmunoCellular Therapeutics Ltd. (IMUC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

ImmunoCellular Therapeutics is a clinical-stage company focused on the development of immune-based therapies for treating brain and other cancers. The company has commenced a Phase II trial of its lead product candidate ICT-107, which is a dendritic cell-based vaccine targeting … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

PolyMedix, Inc. (PYMX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

PolyMedix is a clinical stage biotechnology company devoted to transforming the treatment of infectious diseases. The company is engaged in developing defensin-mimetics, a new class of antibiotics for treating serious, life-threatening infections that often develop resistance to antibiotics that are … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

TechPrecision Corporation (TPCS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

TechPrecision, through its wholly owned subsidiaries Ranor, Inc. and Wuxi Critical Mechanical Components Co. Ltd., leads the industry in the global manufacturing of precision, large-scale fabricated and machined metal components and systems. The company’s products are used in various markets, … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

AmpliPhi Biosciences Corporation (APHB) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

AmpliPhi Biosciences is a biotechnology company engaged in developing, through the application of its proprietary bacteriophage platform, innovative antibacterial solutions for improving human health. The company’s lead product development programs target Gram negative bacterial infections that are often resistant to … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Agenus, Inc. (AGEN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Agenus is a biotechnology company engaged in the development of treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic – including a number … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Perma-Fix Environmental Services, Inc. (PESI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Perma-Fix Environmental Services is a leader in providing nuclear and mixed waste management services, including managing and treating radioactive and mixed waste for hospitals, research labs and institutions; federal agencies, including the Department of Energy and the Department of Defense; … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Inovio Pharmaceuticals, Inc. (INO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Inovio Pharmaceuticals is revolutionizing vaccines for the prevention and treatment of today’s cancers and infectious diseases. The company’s SynCon vaccines are designed to provide universal cross-strain protection against both known and newly emergent unmatched strains of pathogens, such as influenza. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment